
'Think about others': Queen's astonishing vaccine comment
The Queen called her Covid-19 vaccine experience "quite harmless".
The Queen called her Covid-19 vaccine experience "quite harmless".
OPINION: Sixty per cent of the world's vaccine supply has gone to the world's wealthiest.
Ardern explained why, unlike other world leaders, she will not rush to take the vaccine.
Vaccination campaign will target the hesitant 'low-hanging fruit'.
EDITORIAL: Rollout to frontline workers and household contacts expected in first quarter.
Successful vaccine roll-out could lift other coverage rates - but hurt them if done badly.
A Covid-19 vaccine information campaign will start this month.
"Come with me if you want to live!" Star takes to Twitter to urge people to get vaccine.
50% of high-income countries already deploying vaccines — but 0% of poor countries are.
New York Times: The lopsided distribution of vaccines appears certain to worsen inequity.
Dealing with the pandemic has shown world at its best and worst.
The Covid fightback has given Sir David Attenborough heart for the climate battle.
"If a woman starts to grow a beard, they will not have anything to do with it."
New York Times: There are 10 ingredients in Pfizer's vaccine. None of them will track you.
A look at five stubborn myths around Covid-19 that refuse to die.
Health authorities are keeping a close watch for any unexpected side effects of vaccines.
Black Panther's Letitia Wright was tipped to take over but she may have ruined that.
EDITORIAL: For every big achievement, there have been many uninspiring moments this year.
New York Times: The US must choose between preventing death or curbing the virus's spread.
A major step toward eventually ending the pandemic announced - when will NZ be in line?
Britain's frontline healthcare workers and nursing home residents are first in line.
The distribution of a limited amount of vaccine is to be discussed by an expert committee.
Covid-19 offers G20 members chance to cooperate for greater good - but will they?
A Covid-19 vaccine could be here early next year. A top immunologist explains the science.
Local contender says it has advantages in its approach, logistics and cost.
Vulnerable people and frontline Covid-19 workers will be first up for the vaccine.
The fear of leaving home during a pandemic has caused a drop in infant immunisation rates.
UK-based NZ journalist Richard Adams was among several hundred volunteers.
NZ has also signed with Pfizer, which says it's manufacturing at scale as trials continue.